Role of a specialist pharmacist in the management of adalimumab in patients with inflammatory bowel disease (Record no. 15998)

MARC details
000 -LEADER
fixed length control field a
003 - CONTROL NUMBER IDENTIFIER
control field OSt
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20240105115230.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 220119b xxu||||| |||| 00| 0 eng d
040 ## - CATALOGING SOURCE
Original cataloging agency AIKTC-KRRC
Transcribing agency AIKTC-KRRC
100 ## - MAIN ENTRY--PERSONAL NAME
9 (RLIN) 15498
Author Hegner, Johannes
245 ## - TITLE STATEMENT
Title Role of a specialist pharmacist in the management of adalimumab in patients with inflammatory bowel disease
250 ## - EDITION STATEMENT
Volume, Issue number Vol.13 (11)
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Place of publication, distribution, etc. Bhopal
Name of publisher, distributor, etc. Innovare Academic Sciences Pvt Ltd
Year 2021
300 ## - PHYSICAL DESCRIPTION
Pagination 30-33p.
520 ## - SUMMARY, ETC.
Summary, etc. Objective: The management of inflammatory bowel disease (IBD) patients on complex medications such as biologic disease-modifying anti-rheumatic drugs (DMARD) requires close supervision. At East Sussex NHS Healthcare Trust (ESHT), the multi-disciplinary team (MDT) already looking after these patients could benefit from the additional knowledge and support from a specialist pharmacist (SP).<br/><br/>Methods: To assess if the MDT could benefit from an SP, all IBD patients on the DMARD adalimumab were identified. The patient records were screened for patient demographic data, clinical assessment and investigations, treatment, and follow-up clinics.<br/><br/>Results: 162 patients at ESHT were identified as being on adalimumab treatment for either Crohn’s Disease (77%) or Ulcerative Colitis (23%). Disease activity scores, a clinical measure of IBD severity, were infrequently recorded (1%) on patient letters. Evidence of a biologic screen, a series of investigations to ensure safety in a biologic treatment, was only evident in one-third of patients. Clinic review of patients recently started on adalimumab and annual review of stable patients occurred 43% and 26% respectively.<br/><br/>Conclusion: The results indicate that there is a need for an additional member to support the IBD MDT in managing this cohort of patients. An SP is uniquely positioned to fill this gap. They have extensive knowledge in drug indication, therapeutic drug monitoring, and side-effect profiles. Similar studies have been identified that support SP in this role.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
9 (RLIN) 7368
Topical term or geographic name entry element Hospital and Clinical Pharmacy
653 ## - Keywords
Keywords Medication
653 ## - Keywords
Keywords Inflammatory bowel disease
700 ## - ADDED ENTRY--PERSONAL NAME
9 (RLIN) 15499
Co-Author Patel, Janki
700 ## - ADDED ENTRY--PERSONAL NAME
9 (RLIN) 15500
Co-Author Fong, Steven
700 ## - ADDED ENTRY--PERSONAL NAME
9 (RLIN) 15501
Co-Author Jeffs, Simon
773 0# - HOST ITEM ENTRY
Place, publisher, and date of publication Bhopal Innovare Academic Sciences Pvt Ltd
International Standard Serial Number 2656-0097
Title International journal of pharmacy and pharmaceutical science
856 ## - ELECTRONIC LOCATION AND ACCESS
URL https://innovareacademics.in/journals/index.php/ijpps/article/view/42451/25565
Link text Full Article
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Source of classification or shelving scheme Dewey Decimal Classification
Koha item type Articles Abstract Database
Holdings
Withdrawn status Lost status Source of classification or shelving scheme Damaged status Not for loan Collection code Home library Current library Shelving location Date acquired Total Checkouts Barcode Date last seen Price effective from Koha item type
    Dewey Decimal Classification     Circulation School of Pharmacy School of Pharmacy Archieval Section 19/01/2022   2022-0127 19/01/2022 19/01/2022 Articles Abstract Database
Unique Visitors hit counter Total Page Views free counter
Implemented and Maintained by AIKTC-KRRC (Central Library).
For any Suggestions/Query Contact to library or Email: librarian@aiktc.ac.in | Ph:+91 22 27481247
Website/OPAC best viewed in Mozilla Browser in 1366X768 Resolution.